BACH-CUC TRAN: Open Payments
NPI 1861822769 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,987 in 227 payments from 23 companies in 2025. Trend: 2023 $622 · 2024 $1,081 · 2025 $3,987
Food & beverage: $3,809Education: $179
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 42 | $632 |
| ABBVIE INC. | 32 | $450 |
| LEO Pharma Inc. | 26 | $382 |
| Incyte Corporation | 13 | $274 |
| Regeneron Healthcare Solutions, Inc. | 12 | $259 |
| Janssen Biotech, Inc. | 9 | $249 |
| Organon LLC | 13 | $208 |
| Almirall LLC | 14 | $188 |
| Galderma Laboratories, L.P. | 12 | $186 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $175 |
Products named: Zoryve, ADBRY, DUPIXENT, SKYRIZI, OPZELURA, TREMFYA, Seysara, Cabtreo.
Industry payments across TX — which companies pay providers there.
